Topical analgesic combinations for bortezomib neuropathy

J Pain Symptom Manage. 2009 Mar;37(3):e3-5. doi: 10.1016/j.jpainsymman.2008.09.002. Epub 2009 Jan 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Topical
  • Adrenergic alpha-Agonists / administration & dosage
  • Adrenergic alpha-Agonists / therapeutic use
  • Amines / administration & dosage
  • Amines / therapeutic use
  • Analgesics / administration & dosage
  • Analgesics / therapeutic use*
  • Boronic Acids / adverse effects*
  • Boronic Acids / therapeutic use
  • Bortezomib
  • Clonidine / administration & dosage
  • Clonidine / therapeutic use
  • Cyclohexanecarboxylic Acids / administration & dosage
  • Cyclohexanecarboxylic Acids / therapeutic use
  • Drug Combinations
  • Excitatory Amino Acid Antagonists / administration & dosage
  • Excitatory Amino Acid Antagonists / therapeutic use
  • Gabapentin
  • Gels
  • Humans
  • Ketamine / administration & dosage
  • Ketamine / therapeutic use
  • Male
  • Middle Aged
  • Pain Measurement
  • Paraproteinemias / complications
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / drug therapy*
  • Protease Inhibitors / administration & dosage
  • Protease Inhibitors / therapeutic use*
  • Pyrazines / adverse effects*
  • Pyrazines / therapeutic use
  • Walking
  • gamma-Aminobutyric Acid / administration & dosage
  • gamma-Aminobutyric Acid / therapeutic use

Substances

  • Adrenergic alpha-Agonists
  • Amines
  • Analgesics
  • Boronic Acids
  • Cyclohexanecarboxylic Acids
  • Drug Combinations
  • Excitatory Amino Acid Antagonists
  • Gels
  • Protease Inhibitors
  • Pyrazines
  • gamma-Aminobutyric Acid
  • Ketamine
  • Bortezomib
  • Gabapentin
  • Clonidine